FDA Approves Voluven To Treat Serious Blood Volume Loss During And After Surgery

The U.S. Food and Drug Administration today approved Voluven, an intravenous solution that prevents and treats a dangerous loss of blood volume, a condition that sometimes occurs during and after surgery. Significant blood losses can cause a rapid drop in the volume of red blood cells and plasma circulating through the body. This can lead to shock, which is potentially fatal. [click link for full article]

More: continued here

Filed under: Blood on December 30th, 2007